Natural Products Association sues FDA over anti-aging ingredient NMN – article The U.S. Food and Drug Administration blindsided and incensed the supplement industry in 2022 when it determined β-nicotinamide mononucleotide (NMN) could not be marketed in dietary supplement products. Since then, the NMN market has stumbled. Last month, NPA (Natural Products Association) filed what could be a far-reaching suit claiming that the ingredient should not be excluded from the definition of a dietary supplement. |